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Abstract
AIM: To determine the prevalence of non-Helicobacter
pylori (H pylori)-related duodenal ulcer in patients with
acid-peptic diseases.
METHODS: Medical records of patients who attended the
Gastroenterology Department at Aga Khan University
Hospital from 1999 to 2001 and had endoscopic diagnosis
of duodenal ulcers were reviewed. Duodenal ulcer associated
with H pylori was diagnosed on the basis of endoscopy,
rapid urease test and histopathology whereas histories
of aspirin or other non-steroidal anti-inflammatory drugs
(NSAIDs) related duodenal ulcers. Non-H pylori, non-NSAID
duodenal ulcers were those without H pylori infection and
history of NSAID intake. Co-morbid conditions associated
were noted.
RESULTS: Of 2 260 patients, 10% (217/2 260) had
duodenal ulcer. Duodenal ulcer related to H pylori infection
accounted for 53% (116/217), NSAID-related 10% (22/217),
non-H pylori non-NSAID 29% (62/217), and 8% (17/217)
had both H pylori infection and histories of NSAID intake.
Fifteen percent (18/116) patients had past histories of
peptic ulcer disease in H pylori infection, while 8% (5/62)
in non-H pylori non-NSAID ulcer. Co-morbid conditions in
H pylori infection were seen in 23% (27/116) and 34%
(21/62) in non-H pylori non-NSAID ulcer.
CONCLUSION: Incidence of H pylori infection related with
duodenal ulcer is common. In the presence of co-morbids,
non-H pylori and non-NSAID duodenal ulcer is likely to be
present.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
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Peptic ulcer is a leading cause of morbidity and mortality.
Helicobacter pylori (H pylori) infection and nonsteroidal
anti-inflammatory drugs (NSAIDs) are recognized as the
most important causes of peptic ulcer disease. H pylori
infection is considered as a prerequisite for duodenal and
gastric ulcers[1,2]. The widespread use of NSAIDs has led to
an increased incidence of ulcer complications. There has
been an increase in admission for ulcer related complications
among elderly people, which is attributed to the increased
use of NSAIDs and low-dose aspirin[3]. An estimated 16 500
patients with arthritis die from the gastrointestinal toxicity
of NSAIDs every year[4]. The decline in prevalence of H pylori
infection in developed countries has changed the pattern of
peptic ulcer diseases[5]. Studies from North America showed
that 11-44% of peptic ulcers were not related to either of the
two factors[6,7]. In a meta-analysis of duodenal ulcer trials in
North America, 20% of patients had ulcer recurrence within
6 mo after the eradication of H pylori[8]. This is in contrast
with studies from Asia where the prevalence of H pylori
infection is high and that of ulcers not related to H pylori or
NSAIDs is very low[9,10]. In Pakistan, H pylori exposure rate
increases with advancement of age and lowering of socio-
economic status[11]. In a study, the overall exposure rate to
H pylori in children was 33% while in a group of adult dyspeptic
patients undergoing upper gastrointestinal endoscopy, the
prevalence of  H pylori infection investigated by histology
and rapid urease test revealed that H pylori was associated
with 85% cases of duodenal ulcer[11,12]. The pattern of duodenal
ulcer in Karachi, Pakistan, extending over 13 year from
June 1976 to June 1989, demonstrated that duodenal ulcer
occurred predominantly between the 3rd and 5th decade of
life with a male-female ratio of 6:1[13]. History of NSAID
intake was present in only 5% of these cases[13]. The aim of
this study was to determine the prevalence of  non-H pylori-
related duodenal ulcer in our patients.
MATERIALS AND METHODS
This retrospective study was conducted at Aga Khan
University Hospital, Karachi, Pakistan. It is a tertiary care
center and used as a referral center for patients from all
over the country. Medical records of patients who attended
the endoscopy unit of  Gastroenterology Department at Aga
Khan University Hospital from 1999 to 2001 and ICD-9-
CM coded as duodenal ulcers diagnosed by esophagogastr-
oduodenoscopy (EGD) were reviewed. These patients included
all referrals from both outpatient and hospital inpatient
services. All the patients were included only once for analysis.
Of these, 49% (1 115/2 260) patients had chronic gastritis,
9% (198/2 260) gastric ulcer, 32% (730/2 260) duodenitis
and 10% (217/2 260) duodenal ulcer. H pylori infection
was confirmed by rapid urease test and histopathology, which
was later used as the gold standard for the diagnosis. Age,
sex, co-morbid conditions, history of aspirin, NSAIDs,
proton pump inhibitor (PPI), histamine-2 receptor blocker
(H2-RB), antibiotics usage, etc., were noted. Co-morbid
conditions included hypertension, ischemic heart disease,
diabetes mellitus, dyslipidemia, arthritis, etc. NSAID/aspirin
usage was  defined as ingestion of at least one dose within
4 wk before endoscopy. The current treatment of duodenal
ulcer and symptomatic relief that followed was noted. The
treatment consisted of a PPI alone or in combination of
clarithromycin and amoxicillin at a recommended dose for
1 wk[14]. Complete relief was defined requiring no further
medication while partial relief required maintenance
treatment with a PPI or H2-RB. The risk factors associated
with peptic ulcer diseases such as smoking and alcoholism
were also noted. The endoscopic lesions were defined as
duodenal ulcer with a break of ≥ 5 mm in the mucosal
surface with an apparent depth, duodenitis and signs of
active bleeding such as oozing and visible blood vessels.
Rapid urease test and histopathology results were also noted.
Histopathology documented H pylori infection in the
presence of  Gram negative curved bacilli on staining with
hematoxylin-eosin (HE) in the presence of inflammation
that was graded according to Sydney classification. In
doubtful cases, Giemsa stain was used to stain the slides.
Statistical analysis
Results were expressed as mean±SD, with median range for
all continuous variables (age, dose, etc.) and number (percentage)
for categorical data (gender, etc.). Univariate analysis was
performed using Pearson’s 2 test, Fischer-exact test and
the difference in mean was evaluated by independent sample
t test wherever appropriate. P<0.05 was considered statistically
significant. Statistical interpretation of  data was performed
using the computerized software program SPSS version 10.0.
RESULTS
The number of  EGDs performed for upper gastrointestinal
symptoms over this period was 9 000. Of these, 2 260/9 000
had gastroduodenal diseases with H pylori infection-related
duodenal ulcer 53% (116/217), NSAID related 10% (22/217),
non-H pylori non-NSAID 29% (62/217), and both H pylori
and NSAID related 8% (17/217) (Table 1). Those with
NSAID-related duodenal ulcer had the highest mean age
of 62±16.2 years and lowest of 41±14.3 years in H pylori
infection. In all groups there was a male dominance.
Duodenal ulcer related to NSAID use and H pylori infection
Patients with NSAID-related duodenal ulcers had a higher
male: female ratio of 4:1 with mean age of 62±16 years
(Table 1). Abdominal pain was common in H pylori infection
54% (63/116) however, symptoms of abdominal pain,
hematemesis and melena were relatively more in those
with NSAID related duodenal ulcer covering 36% (8/22)
(Table 1). Endoscopic duodenitis and signs of  active
bleeding were seen in those with H pylori infection-related
and NSAID-related duodenal ulcers (Table 1). Patients with
both H pylori and NSAID-related duodenal ulcers had no
Table 1  Clinical detail of the patients with duodenal ulcer (mean±SD)
                  H pylori NSAIDs               Non-H pylori               H pylori and
Variables                   infection related       non-NSAIDs related            NSAIDs related
                  (n = 116) (n = 22) (n = 62)  (n = 17)
Gender
    Male      80      18     42      11
    Female      36       4     20       6
Mean age±SD 41±14.3 62±16.2 42±17 53±13.6
Symptoms
    Abdominal pain      63       6     30       8
    Non-specific      10       4      7       3
    AHM      10       8     12       6
    Bloating      33       4     13       3
Past history
    Peptic ulcer      18       4      5       1
    Co-morbid      27      13     21      11
Endoscopy
    Duodenitis      42       6     24       4
    Active bleed       8       4      4       2
Therapy
    Triple therapy      74       5     14      11
    PPI      37      14     43       6
    H2-RB       3       2      4       -
Symptom relief
    Complete      69 P = 0.09      17     47      12
    Partial      47       5     15       5
AHM = abdominal pain with hematemesis and melena.
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distinguishing features.
H pylori and non-H pylori non-NSAID duodenal ulcer
H pylori and non-H pylori non-NSAID duodenal ulcer had a
similar male:female ratio and mean age (Table 1). Co-morbid
conditions were more common in non-H pylori non-NSAID,
which were 34% (21/62) and 23% (27/116) in H pylori,
respectively (Table 2). In the presence of  co-morbid
conditions, the likelihood of non-H pylori non-NSAID
duodenal ulcer was twice that of H pylori infection odds
ratio: 1.7; 95%CI: (0.8-3.5). Symptoms, endoscopic duodenitis
and signs of active bleeding were almost equally common
in both groups (Table 1).
Treatment of duodenal ulcer related to H pylori infection,
NSAIDs use and non-H pylori, non-NSAIDs
Triple therapy was administered to 64% (74/116) patients
with H pylori infection, while PPI was used in 69% (43/62)
non-H pylori non-NSAID ulcers and in 68% (15/22)
NSAID-related ulcers (Table 1).  These forms of  treatment
were associated with complete symptom relief of H pylori
infection in 59% (69/116), NSAID-related ulcer in 77%
(17/22) and non-H pylori non-NSAID ulcer in 76% (47/62),
with partial relief in 41% (47/116), 23% (5/22) and 24%
(15/62), respectively (P = 0.09, Table 1).
DISCUSSION
It is known that not all ulcers are caused by H pylori and
that there is evidence that the proportion of non-H pylori
ulcers is common. The present study demonstrated that
H pylori infection related duodenal ulcers accounted for 53%
and those associated with NSAIDs 10% (Table 1). The
NSAIDs used were conventional and not selective COX-2
inhibitors. The mean age and the male to female ratio of
patients with NSAID-related duodenal ulcer were compa-
ratively higher than those of  other three groups (Table 1).
We did not find any association between risk factors such
as smoking and alcohol intake with duodenal ulcer in any
group. Abdominal pain was frequent in all groups, the
combination of abdominal pain, hematemesis and melena
was prominently seen in association with non-H pylori non-
NSAIDs. Past history of peptic ulcer diseases was present
in H pylori infection, none of these patients with past histories
of peptic ulcer diseases was found to be on maintenance
PPI or H2-RB. In keeping with other studies, co-morbid
conditions were commonly associated with non-H pylori non-
NSAID-related duodenal ulcer[9,15]. As the sample size was
small, it was not sufficient to compare these co-morbid
conditions individually in each of the four groups. Endoscopic
duodenitis and signs of active bleeding on endoscopy were
not prominent in any particular group (Table 1). Duodenal
ulcer related to H pylori was treated with triple therapy but
only 56% became completely symptom free (Table 1). This
might be attributed to yet undefined proportion of non-
ulcer dyspepsia patients with co-existent carriage of H pylori.
The implications of this study are that in this group of
patients the incidence of H pylori infection related duodenal
ulcer compared with previous study by Kazi et al[12], was
low, this might be attributed to the eradication therapy of
H pylori infection, improvement of socio-economic and living
conditions. Also, practice of indiscriminate use of antibiotics
in our society might have contributed to this. Non-H pylori
non-NSAID duodenal ulcers were also present in our
population where there is a high incidence of H pylori
infection. Non-H pylori non-NSAIDs-related duodenal ulcers
were found in 29% (Table 1). However, a high incidence
of non-H pylori non-NSAIDs duodenal ulcer on a retrospective
study needs confirmation prospectively. Also, some cases
of H pylori infection might have been missed on both rapid
urease test and histopathology. It is also known that in some
of the critically ill patients with co-morbid conditions, stress-
related ulcers may occur. However, none of our patients
was critically ill or from intensive care units. The mean age
of our patients with H pylori infection and non-H pylori non-
NSAID duodenal ulcer was the same in contrast to studies
in the West where non-H pylori non-NSAID duodenal ulcer
patients were of a higher age[9]. This can be explained by
H pylori, host and environmental factors all having a role in
peptic ulcer diseases. Etiological factors for the development
of non-H pylori non-NSAID duodenal ulcer remain to be
identified. In the presence of effective prophylactic agents,
ulcer complications related to NSAIDs were high in our
elderly patients.
In conclusion, H pylori infection-related duodenal ulcer
is still common while NSAID-related duodenal ulcers occur
in older age group. In the presence of co-morbid conditions,
non-H pylori non-NSAID duodenal ulcers are likely to be
present.
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